Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470424) titled 'A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults' on March 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
Primary Sponsor: University of Oxford
Condition:
Malaria
Intervention:
Drug: Piperaquine
Drug: Artesunate-pyronaridine (Pyramax)
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: June 1, 2026
Target Sample Size: 24
Countries of Recruitment:
Thailand
To know more, visit https://clin...